Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy
- 1 October 2008
- journal article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 43 (2), 180-183
- https://doi.org/10.1016/j.jcv.2008.06.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hunting for the owl's eye in acute severe colitis: the role of cytomegalovirusDigestive and Liver Disease, 2004
- Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsClinical Infectious Diseases, 2002
- Cytomegaloviral enterocolitisDiseases of the Colon & Rectum, 1999
- Cytomegalovirus as an Exacerbating Factor in Ulcerative ColitisJournal of Clinical Gastroenterology, 1994
- Cytomegalovirus reactivation and tumour necrosis factorThe Lancet, 1994
- Cytomegalovirus infection associated with onset of inflammatory bowel diseaseDigestive Diseases and Sciences, 1993
- Acute ulcerative proctocolitis associated with primary cytomegalovirus infectionArchives of Internal Medicine, 1990
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989
- Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy.Gut, 1986
- Cytomegalovirus (CMV) in the Compromised Host(s)Annual Review of Medicine, 1977